
SOLIGENIX, INC.
SOLIGENIX, INC. (SNGX)
WebsitePrice
Market cap
Next catalystExpected 2H 2026SGX945 — planned placebo-controlled follow-on study · Trial initiationCompany source ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved